Retrieval of lost patients in the system for hepatitis C microelimination: a single-center retrospective study

[1]  H. Yen,et al.  Direct-acting antiviral treatment for Hepatitis C Virus in geriatric patients: a real-world retrospective comparison between early and late elderly patients , 2021, PeerJ.

[2]  E. Ramírez de Arellano,et al.  HCV microelimination strategies: An interventional study in diagnosed patients without access to the system , 2021, Liver international : official journal of the International Association for the Study of the Liver.

[3]  Y. Kondo,et al.  Establishing Efficient Systems through Electronic Medical Records to Promote Intra-hospital Referrals of Hepatitis Virus Carriers to Hepatology Specialists: A Multicenter Questionnaire-based Survey of 1,281 Healthcare Professionals , 2021, Internal medicine.

[4]  Ming‐Lung Yu,et al.  Scaling up the in-hospital hepatitis C virus care cascade in Taiwan , 2020, Clinical and molecular hepatology.

[5]  H. Yen,et al.  Interferon-Free Anti-HCV Therapy Has a Better Treatment Response Rate and Adherence Than Interferon-Based Therapy for Patients With HCV/HIV Coinfection: A Single-Center Retrospective Study , 2020 .

[6]  R. Dhiman,et al.  Hepatitis C Virus Elimination by 2030: Conquering Mount Improbable , 2020, Clinical liver disease.

[7]  S. Llerena,et al.  Telemedicine efficiently improves access to hepatitis C management to achieve HCV elimination in the penitentiary setting. , 2020, The International journal on drug policy.

[8]  Y. Eguchi,et al.  Management of Hepatitis B Surface Antigen and Hepatitis C Antibody-Positive Patients by Departments Not Specializing in Hepatology at a Suburban University Hospital in Japan: A Single-Center Observational Study , 2020, International journal of general medicine.

[9]  J. Lazarus,et al.  Accelerating the elimination of hepatitis C in Kuwait: An expert opinion , 2020, World journal of gastroenterology.

[10]  H. Yen,et al.  Glecaprevir–pibrentasvir for chronic hepatitis C: Comparing treatment effect in patients with and without end-stage renal disease in a real-world setting , 2020, PloS one.

[11]  L. Bujanda,et al.  Linkage to care strategy for the micro-elimination of hepatitis C among parenteral drug users on methadone replacement therapy in Gipuzkoa. , 2020, Revista espanola de enfermedades digestivas : organo oficial de la Sociedad Espanola de Patologia Digestiva.

[12]  V. Wong,et al.  Management of patients with liver derangement during the COVID-19 pandemic: an Asia-Pacific position statement , 2020, The Lancet Gastroenterology & Hepatology.

[13]  H. Karimi-Sari,et al.  COVID‐19 and viral hepatitis elimination programs: Are we stepping backward? , 2020, Liver international : official journal of the International Association for the Study of the Liver.

[14]  S. Vervoort,et al.  The balancing perspective of hard-to-reach hepatitis C patients who were lost to follow-up: A qualitative study , 2020, PloS one.

[15]  S. A. Soelar,et al.  Find the Missing Millions: Malaysia’s experience with nationwide hepatitis C screening campaign in the general population , 2020, Journal of viral hepatitis.

[16]  G. Papandreou,et al.  Securing sustainable funding for viral hepatitis elimination plans , 2019, Liver international : official journal of the International Association for the Study of the Liver.

[17]  K. Lan,et al.  Direct-acting antivirals for patients with chronic hepatitis C and hepatocellular carcinoma in Taiwan. , 2019, Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi.

[18]  C. Hoebe,et al.  Retrieval and re-evaluation of previously diagnosed chronic hepatitis C infections lost to medical follow-up in the Netherlands , 2019, European journal of gastroenterology & hepatology.

[19]  Sek-Kwong Poon,et al.  Improving medication safety by cloud technology: Progression and value-added applications in Taiwan , 2019, Int. J. Medical Informatics.

[20]  Wei Li,et al.  Hepatitis C screening in hospitals: find the missing patients , 2019, Virology Journal.

[21]  A. Wensing,et al.  REtrieval And cure of Chronic Hepatitis C (REACH): Results of micro‐elimination in the Utrecht province , 2018, Liver international : official journal of the International Association for the Study of the Liver.

[22]  R. Pwu,et al.  Achieving hepatitis C elimination in Taiwan-Overcoming barriers by setting feasible strategies. , 2018, Journal of the Formosan Medical Association = Taiwan yi zhi.

[23]  M. Tsai,et al.  Changing seroprevalence of hepatitis C virus infection among HIV-positive patients in Taiwan , 2018, PloS one.

[24]  M. Klemt-Kropp,et al.  Re-evaluation of chronic hepatitis B and hepatitis C patients lost to follow-up: results of the Northern Holland hepatitis retrieval project , 2018, Hepatology, Medicine and Policy.

[25]  N. Kawada,et al.  Putting “sticky notes” on the electronic medical record to promote intra-hospital referral of hepatitis B and C virus-positive patients to hepatology specialists: an exploratory study , 2016, BMC Infectious Diseases.

[26]  C. Umscheid,et al.  The Treatment Cascade for Chronic Hepatitis C Virus Infection in the United States: A Systematic Review and Meta-Analysis , 2014, PloS one.

[27]  H. Yen,et al.  Decreased mitochondrial deoxyribonucleic acid and increased oxidative damage in chronic hepatitis C. , 2012, World journal of gastroenterology.

[28]  Hilde van der Togt,et al.  Publisher's Note , 2003, J. Netw. Comput. Appl..